The study indicates that the critical ingredient is omega-3 fatty acids that was linked to lower risk of major CVD events such as heart attacks and strokes by about a sixth in high-risk people who ate two servings of fish rich in omega-3 each week.
#LIFEHACKS: Ready or not, daylight saving time arrives this Sunday, March 14th. We’ll be turning the clocks forward an hour, which will lead to lighter skies later in the day, but it can have some not-so-sunny effects on our health. Here are some tips to help you cope!
#LIFEHACKS: Ready or not, daylight saving time arrives this Sunday, March 14th. We’ll be turning the clocks forward an hour, which will lead to lighter skies later in the day, but it can have some not-so-sunny effects on our health. Here are some tips to help you cope!
Winhealth Pharma and Merz Collaborate on Hepa-Merz to benefit patients with liver disease in China
HANG ZHOU, China, March 9, 2021 /PRNewswire/ On Feb. 26
th, 2021, Hongkong Winhealth Pharma Group Co., Ltd (hereinafter referred to as Winhealth Pharma ) signed a strategic cooperation agreement with Merz Pharmaceuticals GmbH (hereinafter referred to as Merz ). The strategic cooperation between the two parties marks the obtainment of Winhealth Pharma for the exclusive commercial rights of Hepa-Merz (L-ornithine L-aspartate, an important product under Merz product portfolio) in China.
About L-ornithine L-aspartate and hepatic encephalopathy (HE)
L-ornithine L-aspartate (LOLA) is a stable salt of two amino acids that stimulates ammonia detoxification by increasing urea synthesis in the liver and muscle, thereby reducing the blood ammonia content in the brain which causes hepatic encephalopathy in cirrhotic patients.